Abstract:Abstract In this retrospective, multicentre, observational cohort study, we sought to determine the clinical, radiological, EEG, genetics and neuropathological characteristics of mitochondrial stroke-like episodes and to identify associated risk predictors. Between January 1998 and June 2018, we identified 111 patients with genetically determined mitochondrial disease who developed stroke-like episodes. Post-mortem cases of mitochondrial disease (n = 26) were identified from Newcastle Brain Tissue Resource. The primary outcome was to interrogate the clinico-radiopathological correlates and prognostic indicators of stroke-like episode in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS). The secondary objective was to develop a multivariable prediction model to forecast stroke-like episode risk. The most common genetic cause of stroke-like episodes was the m.3243A>G variant in MT-TL1 (n = 66), followed by recessive pathogenic POLG variants (n = 22), and 11 other rarer pathogenic mitochondrial DNA variants (n = 23). The age of first stroke-like episode was available for 105 patients [mean (SD) age: 31.8 (16.1)]; a total of 35 patients (32%) presented with their first stroke-like episode ≥40 years of age. The median interval (interquartile range) between first and second stroke-like episodes was 1.33 (2.86) years; 43% of patients developed recurrent stroke-like episodes within 12 months. Clinico-radiological, electrophysiological and neuropathological findings of stroke-like episodes were consistent with the hallmarks of medically refractory epilepsy. Patients with POLG-related stroke-like episodes demonstrated more fulminant disease trajectories than cases of m.3243A>G and other mitochondrial DNA pathogenic variants, in terms of the frequency of refractory status epilepticus, rapidity of progression and overall mortality. In multivariate analysis, baseline factors of body mass index, age-adjusted blood m.3243A>G heteroplasmy, sensorineural hearing loss and serum lactate were significantly associated with risk of stroke-like episodes in patients with the m.3243A>G variant. These factors informed the development of a prediction model to assess the risk of developing stroke-like episodes that demonstrated good overall discrimination (area under the curve = 0.87, 95% CI 0.82–0.93; c-statistic = 0.89). Significant radiological and pathological features of neurodegeneration were more evident in patients harbouring pathogenic mtDNA variants compared with POLG: brain atrophy on cranial MRI (90% versus 44%, P < 0.001) and reduced mean brain weight (SD) [1044 g (148) versus 1304 g (142), P = 0.005]. Our findings highlight the often idiosyncratic clinical, radiological and EEG characteristics of mitochondrial stroke-like episodes. Early recognition of seizures and aggressive instigation of treatment may help circumvent or slow neuronal loss and abate increasing disease burden. The risk-prediction model for the m.3243A>G variant can help inform more tailored genetic counselling and prognostication in routine clinical practice.

Anatomic & metabolic brain markers of the m.3243A>G mutation: A multi-parametric 7T MRI study

[Audiologic Features of Mitochondrial DNA A3243G Mutation and Its Correlation with Mutation Rate].

Mitochondrial DNA Mutation M.3243a>g is Associated with Altered Mitochondrial Function in Peripheral Blood Mononuclear Cells, with Heteroplasmy Levels and with Clinical Phenotypes.

Neuroimaging in mitochondrial disorders

Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA

[Phenotype Heterogeneity Associated with Mitochondrial DNA A3243G Mutation].

Forecasting stroke-like episodes and outcomes in mitochondrial disease

Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A>G Mutation in Mitochondrial DNA.

Clinical features of mtDNA A3243G mutation in adult patients

A Study of Familial MELAS: Evaluation of A3243G Mutation, Clinical Phenotype, and Magnetic Resonance Spectroscopy-Monitored Progression

Cardiovascular autonomic regulation in patients with 3243A > G mitochondrial DNA mutation

A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt‐ND variants

Defining the nuclear genetic architecture of a common maternally inherited mitochondrial disorder

Long Term Follow Up of a Family with A3243G Mitochondrial Syndrome

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

Brain volumetric deficits in MAPT mutation carriers: a multisite study

Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis

Clinical features of mitochondrial DNA m.3243A>G mutation in 47 Chinese families

Mr spectroscopy from frontal lobe and posterior cingulate gyrus in asymptomatic and symptomatic microtubule-associated protein tau (mapt) mutation carriers

The m.3243A ＞ G mutation load in hair follicles from different scalp regions of patients with MELAS

Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients